Drug intelligence / Profile preview

psychotherapy + methylene blue

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

A combination therapy involving the use of psychotherapy and methylene blue, sometimes paired with red light (photobiomodulation) therapy, is being explored for its potential to enhance neuroplasticity, improve memory, and support mental health conditions such as depression, anxiety, and trauma-related disorders. Methylene blue is a synthetic compound with established medical uses that acts as a mitochondrial enhancer by facilitating electron transport in the respiratory chain. It has antioxidant, anti-inflammatory, neuroprotective, and antimicrobial properties. When combined with psychotherapeutic interventions—especially those targeting memory reconsolidation or fear extinction—methylene blue may augment therapeutic outcomes by improving cellular energy production in neural circuits involved in learning and emotional regulation[3][1][7]. This approach remains investigational but has shown promise in early studies for enhancing cognitive function and supporting recovery from mood disorders.

02

Targets

NOS1 (nNOS)COX7C (Cytochrome c oxidase subunit 7C, mitochondrial)MAOA (Monoamine oxidase A)

Beyond the preview

Go deeper on psychotherapy + methylene blue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on psychotherapy + methylene blue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call